Sort
25,944 grants matching “neurodegeneration”
Cephalopod-Inspired Bioelectronic Control of Cellular Signaling
$888,528Alon A Gorodetsky · University Of California-Irvine · DP2 · FY2024 · GM
Modeling drugs of abuse-HIV interactions using iPSC-derived human cerebral organoids
$888,324Pietro P Sanna · Scripps Research Institute, The · R01 · FY2023 · DA
Project 3: Roles of Tau Levels, Sequence and Interactors in Neural Network Dysfunction of Alzheimer's Disease
$888,001Lennart Mucke · J. David Gladstone Institutes · P01 · FY2021 · AG
Neuroimaging and Plasma Biomarkers Core
$886,119Ilya M Nasrallah · Columbia University Health Sciences · U19 · FY2022 · AG
Systems biology of HIV, methamphetamine and antiretrovirals interactions
$884,928Pietro P Sanna · Scripps Research Institute, The · R01 · FY2017 · DA
Reducing African Americans' Alzheimer's Disease Risk Through Exercise-MCI Cohort (RAATE-MCI)
$884,785Robert Lee Newton · Lsu Pennington Biomedical Research Ctr · R01 · FY2025 · AG
Role of transposon dysregulation in Alzheimer and aging brains revealed by single-cell genomic and transcriptomic analysis
$884,331Eunjung Alice Lee · Boston Children'S Hospital · R01 · FY2022 · AG
Role of clonal somatic mutations in microglia activation and Alzheimerâs disease
$883,191Yue Huang · Boston Children'S Hospital · R56 · FY2023 · AG
Neurodegeneration Underlying Distinct Disabilities in Multiple Sclerosis Using a Cell-Specific, Region-Specific, and Sex-Specific Approach
$881,493Rhonda R Voskuhl · University Of California Los Angeles · R35 · FY2023 · NS
Novel Humanized Mouse Models For Engraftment of Tissue-Specific Human Macrophage Population
$881,450Michael Allen Brehm · Univ Of Massachusetts Med Sch Worcester · R24 · FY2024 · OD
Alzheimer's Disease Hallmark Pathology and Associated Inflammation in the Retina
$880,092Maya Koronyo-Hamaoui · Cedars-Sinai Medical Center · R01 · FY2023 · AG
Connecting TDP-43 Pathology to the Molecular Profiles of Neurodegeneration
$879,816Molly Gale Hammell · New York University School Of Medicine · R01 · FY2024 · NS
Resilience pathways modeling human longevity-promoting ApoE variants in induced pluripotent stem cells
$879,592Lisa M. Ellerby · Buck Institute For Research On Aging · R01 · FY2020 · AG
Resilience pathways modeling human longevity-promoting ApoE variants in induced pluripotent stem cells
$879,592Lisa M. Ellerby · Buck Institute For Research On Aging · R01 · FY2021 · AG
Resilience pathways modeling human longevity-promoting ApoE variants in induced pluripotent stem cells
$879,592Lisa M. Ellerby · Buck Institute For Research On Aging · R01 · FY2018 · AG
Resilience pathways modeling human longevity-promoting ApoE variants in induced pluripotent stem cells
$879,592Lisa M. Ellerby · Buck Institute For Research On Aging · R01 · FY2022 · AG
Resilience pathways modeling human longevity-promoting ApoE variants in induced pluripotent stem cells
$879,592Lisa M. Ellerby · Buck Institute For Research On Aging · R01 · FY2019 · AG
The Neuroimaging Brain Chart Software Suite
$879,586Christos Davatzikos · University Of Pennsylvania · U24 · FY2024 · NS
The Neuroimaging Brain Chart Software Suite
$879,586Christos Davatzikos · University Of Pennsylvania · U24 · FY2025 · NS
Early Markers of Alzheimer Disease
$879,304Susan Resnick · National Institute On Aging · ZIA · FY2023 · AG
Mechanisms of Mutant Prion Protein Aggregation Within Endolysosomal Pathways
$878,731Sandra E Encalada · Scripps Research Institute, The · R01 · FY2024 · AG
Systems biology of HIV, methamphetamine and antiretrovirals interactions
$878,554Pietro P Sanna · Scripps Research Institute, The · R01 · FY2018 · DA
Characterizing the Behavior Profile of Healthy Cognitive Aging
$878,179Patricia A Boyle · Rush University Medical Center · R01 · FY2025 · AG
Neural mechanisms of gait disturbances as individualized digital biomarker trajectories in preclinical dementia
$877,523Ehsan Adeli · Stanford University · R01 · FY2025 · AG
Regulation mechanism and functional genomics of LINE1 RNA in TDP-43 linked neurodegeneration
$877,436Shuying Sun · Johns Hopkins University · R01 · FY2022 · AG